Project Grant R43PS005314
Award Date 9/30/25
Completion Date 9/29/26
Dollars Obligated $234K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Ithaca, NY, USA
Similar Awards
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $1,047,807 Project Grant under the CDC Investigations and Technical Assistance program (CFDA 93.283) to Nanohmics Inc., a small technology development company based in Austin, TX. The grant, with a performance period from September 30, 2025 to September 29, 2027, supports the development of Lateral Flow-Electrochemiluminescent (LF-ECL) test strips and a portable reader system for ultrasensitive detection of foodborne...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $279,270 Project Grant to Advanced Virology Inc. in Philadelphia, PA on September 30, 2025. The grant, funded through the CDC's Investigations and Technical Assistance program (CFDA 93.283), supports the development of "LOW-COST AND HIGH EFFICIENCY DNA-BASED REVERSE GENETICS PLATFORMS FOR MANUFACTURING RNA VIRUS PRODUCTS." The project aims to advance technologies for the production of RNA virus-based products through...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $265,850 Project Grant to SKM Instruments, LLC on Sep 30, 2025 under the CDC Investigations and Technical Assistance program (CFDA 93.283). The grant supports the development of an ULTRA-RAPID OPTICAL PLATFORM FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING (AST) OF PULMONARY NON-TUBERCULOUS MYCOBACTERIAL (NTM) INFECTIONS. The project aims to create an innovative health technology to enhance disease detection and prevention...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $501,200 Project Grant on Sep 30, 2025 to Aptus Biosciences LLC, a minority-owned small business located in Gainesville, Florida, under the CDC's "Prevention of Disease, Disability, and Death by Infectious Diseases" program (CFDA 93.084). The funding will support the development of a rapid, affordable, aptamer-based diagnostic test for Hepatitis C virus. Aptus Biosciences specializes in advanced diagnostic research and...
- The Centers for Disease Control and Prevention (CDC) awarded a $300,000 Project Grant to Pace Diagnostics, Inc. under the CDC Investigations and Technical Assistance program (CFDA 93.283). The funding will support the development of an ultrasensitive urine tuberculosis (TB) antigen rapid detection test for the diagnosis of active TB. The project period is from Sep 30, 2025 to Mar 31, 2026. The CDC Investigations and Technical Assistance program funds research, surveillance, epidemiological...
- The Centers for Disease Control and Prevention (CDC) awarded Seacoast Science, Inc. a $541,648 Project Grant under the CDC Investigations and Technical Assistance program (CFDA 93.283) on September 30, 2025. The purpose of this award is to develop an auto-calibrating air quality monitoring system. Seacoast Science, Inc. is a for-profit company that specializes in advanced chemical sensors, detection devices, and monitoring systems, with a focus on innovative environmental and safety monitoring...
- The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), awarded a $884,453 Project Grant to Brigham & Women's Hospital Inc. to develop a rapid, cost-effective point-of-care (POC) diagnostic test for Hepatitis C Virus (HCV) detection. The 5-year project, which commenced on November 22, 2024, aims to create a highly sensitive and specific HCV antigen (Ag) testing solution that can streamline...
- This $994,658 Project Grant was awarded on September 30, 2025 by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283) to Lo Biosciences, Inc., a minority-owned biotechnology company based in Rockville, Maryland. The award supports the development of a novel remote blood separation device for at-home plasma collection to enable HIV-1 testing. This project aims to create an innovative diagnostic technology that improves the...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $537,619 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Central Florida Board of Trustees. The grant, awarded on March 1, 2025, will support the development of a single biosensor platform for the simultaneous detection of HIV, hepatitis B, and hepatitis C viruses, particularly in resource-limited settings. The project aims to integrate the university's recently...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $776,341 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Illinois on September 16, 2025. The purpose of this grant is to develop a microfluidic cartridge, molecular biology method, biosensor, and detection instrument that can simultaneously detect HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) viral loads from a minimal 100 μL whole blood sample. This...